HCS
XENE icon

Himension Capital (Singapore)’s Xenon Pharmaceuticals XENE Stock Holding History

Himension Capital (Singapore)’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$463K Buy
+7,666
New +$426K 0.03% 148
2026
Q1 		– Sell
-11,279
Closed -$506K – 150
2025
Q4 		$506K Buy
+11,279
New +$474K 0.03% 86

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Himension Capital (Singapore)'s XENE Position: Q2 2026 in Review

Himension Capital (Singapore) opened a new position in Xenon Pharmaceuticals (XENE) in Q2 2026: 7,666 shares worth $463K. The stake represents 0.03% of the portfolio and ranks #148 among its holdings. This is a return to the name: Himension Capital (Singapore) previously reported a position in XENE as recently as Q4 2025.

Himension Capital (Singapore) first reported a position in XENE in Q4 2025 and has held it in 2 quarters since. The position peaked at $506K in Q4 2025. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Himension Capital (Singapore) held 7,666 shares of Xenon Pharmaceuticals worth $463K as of Q2 2026.
  • Xenon Pharmaceuticals was a new Himension Capital (Singapore) position in Q2 2026.
  • Xenon Pharmaceuticals made up 0.03% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #148 holding.
  • Himension Capital (Singapore) first reported a position in Xenon Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Himension Capital (Singapore)'s Xenon Pharmaceuticals position peaked at $506K in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.